Why Magnetic Beads Are Not Ideal for RNA Isolation Anymore
Team Dynamic Matrices | 21 June 2026
Magnetic beads have run molecular biology labs for two decades and they are not going away. We use them ourselves for some steps. But as sequencing demands have grown, particularly for low-input, degraded and multiplexed samples, the limits of bead chemistry have become the bottleneck in many workflows. We built LASSO as an alternative, so this is a partisan post; we have tried to make it a fair one with numbers you can check.
What a bead actually does
A magnetic bead is a solid support. Silica or carboxyl coatings bind nucleic acids by charge and salt-dependent adsorption; streptavidin coatings bind biotinylated probes that in turn hybridise to targets. In both cases the bead surface is the limit. Binding capacity is set by surface area, and every wash and elution has to move liquid past a solid, which is where losses and non-specific carryover happen.
Four limits that now matter
1. Capture is by property, not by sequence. Silica and carboxyl beads bind nucleic acids based on length and charge. They co-isolate rRNA fragments, degraded transcripts, and genomic DNA that share those properties. Selectivity comes from a separate probe step, which adds its own losses.
2. Surface-limited capacity. Streptavidin Dynabeads bind on the order of 0.2 to 0.3 nmol of biotinylated oligonucleotide per milligram of beads (manufacturer data, and our own measurement of about 0.29 nmol/mg). For multiplexed capture panels with hundreds of probes, or for rRNA depletion where the target is 80 to 90 percent of the input, that capacity is the constraint, and the fix is more beads, which means more cost and more non-specific surface.
3. Enzyme dependency. Most bead-based rRNA depletion runs an RNase H digestion; most bead-based library prep chains several enzymatic steps. Enzymes ship cold, expire in months, and vary by lot. Labs treat this as unavoidable overhead. It is not.
4. Harsh elution. Getting a target off a high-affinity surface takes heat, denaturant or competitor. For RNA that is fine; for RNA-protein complexes or native proteins it destroys what you were trying to keep. Our native protein pulldown post covers this.
How sequence-selective phase separation works
LASSO replaces the solid support with a soluble, programmable polymer. Short DNA "catcher" strands are attached to a linear polymer. When they hybridise to their targets and to each other, the polymer network crosslinks and undergoes a phase transition, condensing into a pellet that can be spun down. No bead, no magnet, no enzyme. Targets are released by a gentle displacement or temperature step under near-native conditions.
Because capture happens throughout a soluble polymer rather than on a surface, capacity scales with polymer amount rather than surface area. We measure about 4 nmol of target per milligram of polymer, roughly 8 to 20 times a streptavidin bead. Because selection is by sequence, off-target carryover is lower. Because there are no enzymes, the reagents are stable for about a year at 4 °C (Dynamic Matrices, Angewandte Chemie, 2025; patent WO 2025/196123A1).
Where each approach fits
| Situation | Beads | Sequence-selective phase separation |
|---|---|---|
| Total RNA cleanup from abundant intact sample | Fine | Not needed |
| rRNA depletion, intact RNA | Works, enzyme-dependent | Works, enzyme-free, over 98 percent depletion in our benchmarks |
| rRNA depletion, degraded or FFPE RNA | Efficiency drops | Holds efficiency on fragments |
| Low-input (pg to low ng) | Surface losses dominate | Lower losses, no surface adsorption |
| Multiplexed capture, hundreds of targets | Capacity-limited | Scales with polymer |
| Native protein or RNP recovery | Harsh elution | Mild release |
| Cost per sample for rRNA depletion | Tens of euros with commercial kits | About one euro in reagents at our scale |
| Reagent stability | Cold chain, months | About a year at 4 °C, no freezer |
What labs report after switching
Cleaner rRNA depletion with fewer residual reads, gentler capture from scarce samples, and the removal of cold-chain management for the capture reagent. Workflow time is similar, because sample handling and incubation dominate in both cases. The equipment is a benchtop centrifuge and a heat block, which every lab already has.
What we tell people honestly
Beads are a mature technology with decades of protocol literature; LASSO has a growing but shorter validation record. If your assay is a standard, well-validated bead workflow on intact, abundant RNA, there is no urgent reason to change. If you are fighting capacity, off-target reads, low input, degraded samples or enzyme logistics, the case is strong and we would be glad to run a side-by-side on your samples.
References
- Dynamic Matrices. LASSO: sequence-selective biomolecule isolation by programmable polymer phase separation. Angew Chem Int Ed (2025); patent WO 2025/196123A1.
- Thermo Fisher Scientific. Dynabeads M-280 Streptavidin product data: binding capacity for biotinylated oligonucleotides.
- Adiconis X et al. Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat Methods 10, 623–629 (2013).
- Berensmeier S. Magnetic particles for the separation and purification of nucleic acids. Appl Microbiol Biotechnol 73, 495–504 (2006).
FAQs
No. A centrifuge and a heat block. No magnet rack required.
Comparable. Hybridisation and handling set the time in both.
Yes. The catcher strands can be designed against any nucleic acid sequence, and we are running gDNA capture projects now.
A magnetic bead is a solid support. Silica or carboxyl-coated beads bind nucleic acids by charge and salt-dependent adsorption, so they capture by length and charge rather than by sequence; streptavidin beads bind biotinylated probes that hybridise to specific targets. In both cases the bead surface limits capacity, and washes and elution are where losses and carryover happen. See RNA purification pitfalls.